<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="92507">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02031354</url>
  </required_header>
  <id_info>
    <org_study_id>1308012508</org_study_id>
    <nct_id>NCT02031354</nct_id>
  </id_info>
  <brief_title>A Pilot Study of Dietary Chloride Supplementation on Cardiorenal Function in Heart Failure</brief_title>
  <official_title>Prospective &quot;Pre-post&quot; Pilot Study on the Effects of Dietary Chloride Supplementation on Neurohormonal and Diuretic Function in Patients With Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yale University</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if administration of supplemental chloride in the
      form of lysine chloride to patients with congestive heart failure will affect their
      neurohormonal profile as well as response to diuretics.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This prospective pilot &quot;pre-post&quot; study was designed to determine if supplementation of
      sodium free chloride ion as a lysine chloride to patients with heart failure could improve
      parameters of neurohormonal status and diuretic responsiveness. Volunteers will receive
      Lysine Chloride 7 grams three times daily for three days. At baseline and then again post
      lysine chloride patients will undergo sampling of venous blood for determination of
      neurohormonal parameters in addition to formal diuretic responsiveness testing.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Change in plasma renin activity following lysine chloride administration</measure>
    <time_frame>3 days</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in urinary renin level following lysine chloride administration</measure>
    <time_frame>3 days</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in diuretic response following lysine chloride administration</measure>
    <time_frame>3 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Diuretic response will me evaluated by measuring volume of urine produced following diuretic administration</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Lysine Chloride</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Lysine Chloride</intervention_name>
    <description>Administration of 21g of lysine chloride (7g three times daily) for a period of time of 3 days</description>
    <arm_group_label>Lysine Chloride</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥18 years

          -  Fluency in English

          -  Heart failure requiring loop diuretic therapy

          -  Loop diuretic dose ≥ 80mg/day furosemide equivalents

          -  Stable volume status and diuretic requirement as assessed by treating physician

        Exclusion Criteria:

          -  Unstable heart failure

          -  renal replacement therapy or an estimated GFR &lt; 30 ml/min/1.73m2

          -  Significant bladder dysfunction

          -  History of hepatic failure

          -  Pregnancy

          -  History of hyperinsulinemia/hyperlysinuria
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeffrey M Testani, MD/MTR</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yale University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Olga Laur, BS</last_name>
    <phone>4047236820</phone>
    <email>olga.laur@yale.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Yale New Haven Hospital</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06511</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olga Laur</last_name>
      <phone>404-723-6820</phone>
      <email>olga.laur@yale.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Licata G, Di Pasquale P, Parrinello G, Cardinale A, Scandurra A, Follone G, Argano C, Tuttolomondo A, Paterna S. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects. Am Heart J. 2003 Mar;145(3):459-66.</citation>
    <PMID>12660669</PMID>
  </reference>
  <reference>
    <citation>Kirchner KA, Kotchen TA, Galla JH, Luke RG. Importance of chloride for acute inhibition of renin by sodium chloride. Am J Physiol. 1978 Nov;235(5):F444-50.</citation>
    <PMID>31796</PMID>
  </reference>
  <reference>
    <citation>RUBIN AL, SPRITZ N, MEAD AW, HERRMANN RA, BRAVEMAN WS, LUCKEY EH. The use of L-lysine monomydrochloride in combination with mercurial diuretics in the treatment of refractory fluid retention. Circulation. 1960 Mar;21:332-6.</citation>
    <PMID>14439868</PMID>
  </reference>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 16, 2014</lastchanged_date>
  <firstreceived_date>December 12, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Yale University</investigator_affiliation>
    <investigator_full_name>Jeffrey Testani</investigator_full_name>
    <investigator_title>Assistant Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Lysine Chloride</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
